Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 302

1.

Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints.

Antonell A, Fortea J, Rami L, Bosch B, Balasa M, Sánchez-Valle R, Iranzo A, Molinuevo JL, Lladó A.

J Neural Transm. 2011 Feb;118(2):259-62. doi: 10.1007/s00702-010-0534-0. Epub 2010 Dec 16.

PMID:
21161712
[PubMed - indexed for MEDLINE]
2.

Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.

Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S77-83.

PMID:
21721431
[PubMed - indexed for MEDLINE]
3.

Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients.

Rami L, Fortea J, Bosch B, Solé-Padullés C, Lladó A, Iranzo A, Sánchez-Valle R, Molinuevo JL.

J Alzheimers Dis. 2011;23(2):319-26. doi: 10.3233/JAD-2010-101422.

PMID:
21098971
[PubMed - indexed for MEDLINE]
4.

Longitudinal changes of CSF biomarkers in Alzheimer's disease.

Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK.

J Alzheimers Dis. 2011;25(4):583-94. doi: 10.3233/JAD-2011-101911.

PMID:
21460434
[PubMed - indexed for MEDLINE]
5.

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.

Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM.

Methods. 2012 Apr;56(4):484-93. doi: 10.1016/j.ymeth.2012.03.023. Epub 2012 Apr 6. Review.

PMID:
22503777
[PubMed - indexed for MEDLINE]
6.

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.

Bibl M, Mollenhauer B, Lewczuk P, Esselmann H, Wolf S, Otto M, Kornhuber J, Rüther E, Wiltfang J.

Dement Geriatr Cogn Disord. 2011;31(1):37-44. doi: 10.1159/000322370. Epub 2010 Dec 7.

PMID:
21135556
[PubMed - indexed for MEDLINE]
7.

Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia.

Nägga K, Gottfries J, Blennow K, Marcusson J.

Dement Geriatr Cogn Disord. 2002;14(4):183-90.

PMID:
12411760
[PubMed - indexed for MEDLINE]
8.

Could clinical profile influence CSF biomarkers in early-onset Alzheimer disease?

Koric L, Felician O, Guedj E, Hubert AM, Mancini J, Boucraut J, Ceccaldi M.

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):278-83. doi: 10.1097/WAD.0b013e3181d712d9.

PMID:
20473135
[PubMed - indexed for MEDLINE]
9.

Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.

Sundelöf J, Sundström J, Hansson O, Eriksdotter-Jönhagen M, Giedraitis V, Larsson A, Degerman-Gunnarsson M, Ingelsson M, Minthon L, Blennow K, Kilander L, Basun H, Lannfelt L.

J Alzheimers Dis. 2010;21(2):471-8. doi: 10.3233/JAD-2010-091594.

PMID:
20555147
[PubMed - indexed for MEDLINE]
10.

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.

Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Andreasson U, Zetterberg H, Blennow K, Svensson J.

J Alzheimers Dis. 2011;24(3):537-46. doi: 10.3233/JAD-2011-101878.

PMID:
21297262
[PubMed - indexed for MEDLINE]
11.

Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.

Fagan AM, Shaw LM, Xiong C, Vanderstichele H, Mintun MA, Trojanowski JQ, Coart E, Morris JC, Holtzman DM.

Arch Neurol. 2011 Sep;68(9):1137-44. doi: 10.1001/archneurol.2011.105. Epub 2011 May 9.

PMID:
21555603
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort.

Schoonenboom NS, Reesink FE, Verwey NA, Kester MI, Teunissen CE, van de Ven PM, Pijnenburg YA, Blankenstein MA, Rozemuller AJ, Scheltens P, van der Flier WM.

Neurology. 2012 Jan 3;78(1):47-54. doi: 10.1212/WNL.0b013e31823ed0f0. Epub 2011 Dec 14.

PMID:
22170879
[PubMed - indexed for MEDLINE]
13.

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature.

Lewczuk P, Esselmann H, Bibl M, Beck G, Maler JM, Otto M, Kornhuber J, Wiltfang J.

J Mol Neurosci. 2004;23(1-2):115-22.

PMID:
15126697
[PubMed - indexed for MEDLINE]
14.

Increased total TAU but not amyloid-beta(42) in cerebrospinal fluid correlates with short-term memory impairment in Alzheimer's disease.

Lin YT, Cheng JT, Yao YC, Juo, Lo YK, Lin CH, Ger LP, Lu PJ.

J Alzheimers Dis. 2009;18(4):907-18. doi: 10.3233/JAD-2009-1214.

PMID:
19749420
[PubMed - indexed for MEDLINE]
15.

Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluid.

Schipke CG, Prokop S, Heppner FL, Heuser I, Peters O.

Dement Geriatr Cogn Disord. 2011;31(2):139-45. doi: 10.1159/000322588. Epub 2011 Feb 8.

PMID:
21304219
[PubMed - indexed for MEDLINE]
16.

[The role of CSF markers in the early diagnosis of Alzheimer's disease].

Vos SJ, Visser PJ, Verhey FR.

Tijdschr Psychiatr. 2011;53(9):647-53. Dutch.

PMID:
21898322
[PubMed - indexed for MEDLINE]
Free Article
17.

Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers.

Slats D, Claassen JA, Spies PE, Borm G, Besse KT, van Aalst W, Tseng J, Sjögren MJ, Olde Rikkert MG, Verbeek MM.

Neurobiol Aging. 2012 Apr;33(4):831.e1-9. doi: 10.1016/j.neurobiolaging.2011.07.008. Epub 2011 Aug 31.

PMID:
21880396
[PubMed - indexed for MEDLINE]
Free Article
18.

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.

Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslén M.

J Neurol. 2013 Feb;260(2):620-6. doi: 10.1007/s00415-012-6688-y. Epub 2012 Oct 9.

PMID:
23052602
[PubMed - indexed for MEDLINE]
19.

Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.

Paternicò D, Galluzzi S, Drago V, Bocchio-Chiavetto L, Zanardini R, Pedrini L, Baronio M, Amicucci G, Frisoni GB.

Alzheimers Dement. 2012 Nov;8(6):520-7. doi: 10.1016/j.jalz.2011.10.003. Epub 2012 Jun 6.

PMID:
22677492
[PubMed - indexed for MEDLINE]
20.

Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting.

Dumurgier J, Vercruysse O, Paquet C, Bombois S, Chaulet C, Laplanche JL, Peoc'h K, Schraen S, Pasquier F, Touchon J, Hugon J, Lehmann S, Gabelle A.

Alzheimers Dement. 2013 Jul;9(4):406-13. doi: 10.1016/j.jalz.2012.06.006. Epub 2012 Nov 8.

PMID:
23141384
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk